(Q31103156)

28 June 2017

title

Expected value of sample information for Weibull survival data (English)

1 reference

28 June 2017

Alan Brennan

1

0 references

author name string

Samer A Kharroubi

series ordinal

2

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

28 June 2017

1 reference

28 June 2017

volume

16

1 reference

28 June 2017

issue

11

1 reference

28 June 2017

page(s)

1205-1225

1 reference

Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis

28 June 2017

cites work

1 reference

A Bayesian approach to Weibull survival models--application to a cancer clinical trial.

21 January 2018

1 reference

7 January 2021

Expected value of sample information calculations in medical decision modeling.

1 reference

7 January 2021

Efficient computation of partial expected value of sample information using Bayesian approximation.

1 reference

7 January 2021

Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals.

1 reference

7 January 2021

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

7 January 2021

An economic approach to clinical trial design and research priority-setting

1 reference

7 January 2021

A dynamic programming approach to the efficient design of clinical trials.

1 reference

7 January 2021

Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease

1 reference

7 January 2021

Measures of importance for economic analysis based on decision modeling

1 reference

7 January 2021

Sensitivity analysis and the expected value of perfect information

1 reference

7 January 2021

Assessment and monitoring in clinical trials when survival curves have distinct shapes: a Bayesian approach with Weibull modelling

1 reference

7 January 2021

Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research

1 reference

7 January 2021

Bayesian assessment of sample size for clinical trials of cost-effectiveness

1 reference

7 January 2021

Assurance in clinical trial design

1 reference

7 January 2021

Accurate Approximations for Posterior Moments and Marginal Densities

1 reference

7 January 2021

Value of information literature analysis: a review of applications in health risk management.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.1217

1 reference

28 June 2017

1 reference